GSK2256294A, CAS 1142090-23-0

Product Description: GSK2256294A (GSK 2256294) is a selective and orally active inhibitor of soluble epoxide hydrolase (sEH). GSK2256294A inhibits recombinant human sEH, rat sEH orthologs and murine sEH orthologs with IC50s of 27, 61 and 189 pM, respectively. GSK2256294A can be used for the research of chronic obstructive pulmonary disease (COPD) and cardiovascular disease[1].

Applications: COVID-19-immunoregulation

Formula: C21H24F3N7O

References: [1]Podolin PL, et al. In vitro and in vivo characterization of a novel soluble epoxide hydrolase inhibitor. Prostaglandins Other Lipid Mediat. 2013 Jul-Aug;104-105:25-31.

CAS Number: 1142090-23-0

Molecular Weight: 447.46

Compound Purity: 99.91

Research Area: Cardiovascular Disease

Solubility: DMSO : ≥ 47 mg/mL

Target: Epoxide Hydrolase

• Artikelnummer: MEXHY-19644-10.1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-19644-10.1
• Verpackungseinheit: 10 mM/1 ml
• Mengeneinheit: STK